291
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Eyes are mirror of the brain: comparison of multiple sclerosis patients and healthy controls using OCT

, , , &
Pages 848-855 | Received 24 Sep 2018, Accepted 13 Jan 2019, Published online: 20 Feb 2019

References

  • Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372:1502–1517.
  • McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992; 55:747–752.
  • Petzold A, Wattjes MP, Costello F, et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014; 10:447–458.
  • Gordon-Lipkin E, Calabresi PA. Optical coherence tomography: a quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis. J Neuroimmunol. 2017; 304:93–96.
  • Frohman EM, Fujimoto JG, Frohman TC, et al. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Rev Neurol. 2008; 4:664–675.
  • Barkhof F, Calabresi PA, Miller DH, et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol. 2009; 5:256–266.
  • Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010; 29:144–168.
  • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69:292–302.
  • Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007; 52(Suppl 2): S144–S154.
  • Ferreira CS, Beato J, Falcao MS, et al. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations. Retina (Philadelphia, PA). 2017; 37:529–535.
  • Ingegnoli F, Gualtierotti R, Pierro L, et al. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study. Microvasc Res. 2015; 97:31–36.
  • Altinkaynak H, Duru N, Uysal BS, et al. Choroidal thickness in patients with systemic lupus erythematosus analyzed by spectral-domain optical coherence tomography. Ocul Immunol Inflamm. 2016; 24:254–260.
  • Akcam HT, Capraz IY, Aktas Z, et al. Multiple sclerosis and optic nerve: an analysis of retinal nerve fiber layer thickness and color Doppler imaging parameters. Eye (Lond). 2014; 28:1206–1211.
  • Kal A, Duman E, Sezenoz AS, et al. Evaluation of retrobulbar blood flow and choroidal thickness in patients with rheumatoid arthritis. Int Ophthalmol. 2018; 38:1825–1831.
  • Esen E, Sizmaz S, Demir T, et al. Evaluation of choroidal vascular changes in patients with multiple sclerosis using enhanced depth imaging optical coherence tomography. Ophthalmologica. 2016;235:65–71.
  • Kal A, Oğuz Ulusoy M, Horasanlı B, et al. Effect of fingolimod (FTY720) on choroidal thickness in patients with multiple sclerosis. Mult Scler Relat Disord. 2017; May14:4–7.
  • Tang X, Lan M, Zhang M, et al. Effect of nitric oxide to axonal degeneration in multiple sclerosis via downregulating monocarboxylate transporter 1 in oligodendrocytes. Nitric Oxide. 2017; 67:75–80.
  • Luo X, Shen YM, Jiang MN, et al. Ocular blood flow autoregulation mechanisms and methods. J Ophthalmol. 2015;2015:864871
  • Abalo-Lojo JM, Limeres CC, Gomez MA, et al. Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients. J Neuroophthalmol. 2014; 34:23–28.
  • Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006; 113:324–332.
  • Pueyo V, Martin J, Fernandez J, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler. 2008; 14:609–614.
  • Balk LJ, Cruz-Herranz A, Albrecht P, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016; 263:1323–1331.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.